July 18, 2019 The Council recently expressed strong support for the Lower Health Care Costs Act, which confronts some of the biggest obstacles to bringing costs down in the healthcare
July 18, 2019 The House Energy and Commerce Committee’s Subcommittee on Health recently marked up and voted in favor of drug transparency and surprise billing legislation. No Surprises Act (H.R.
July 18, 2019 The Trump administration announced it will not pursue its proposal to eliminate prescription drug rebates from government-facilitated health plans. While once touted as a critical step in
March 21, 2019 The Council’s Katie Oberkircher spoke with Eric Pachman and Antonio Ciaccia, co-founders of 46Brooklyn—a prescription drug research firm—to demonstrate how to use the tools they’ve created to
Click to read The Council perspective.
Click to read The Council perspective.
March 14, 2018 HHS Secretary Alex Azar and FDA Commissioner Scott Gottlieb want pharmacy benefit managers (PBMs) and health plans to pass on more savings to consumers when they pick
Express Scripts, a pharmacy benefit manager (PBM), is losing health insurer Anthem as a client, after being accused of not negotiating lower prices for prescription drugs.
